-
1
-
-
24644490720
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility systematic evidence review for the U.S. Preventive Services Task Force
-
U.S. Preventive Services Task Force. published correction appears in Ann Intern Med. 2005;143(7):547
-
Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility systematic evidence review for the U.S. Preventive Services Task Force [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):362-379.
-
(2005)
Ann Intern Med
, vol.143
, Issue.5
, pp. 362-379
-
-
Nelson, H.D.1
Huffman, L.H.2
Fu, R.3
Harris, E.L.4
-
2
-
-
24644456397
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement
-
U.S. Preventive Services Task Force. published correction appears in Ann Intern Med. 2005;143(7):547
-
U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann intern Med 2005;143(5):355-361.
-
(2005)
Ann Intern Med
, vol.143
, Issue.5
, pp. 355-361
-
-
-
3
-
-
33645806295
-
Screen-positive rates and agreement among six family history screening protocols for breast/ ovarian cancer in a population-based cohort of 21- to 55-year-old women
-
Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE. Screen-positive rates and agreement among six family history screening protocols for breast/ ovarian cancer in a population-based cohort of 21- to 55-year-old women. Genet Med. 2006;8(3):161-168.
-
(2006)
Genet Med
, vol.8
, Issue.3
, pp. 161-168
-
-
Palomaki, G.E.1
McClain, M.R.2
Steinort, K.3
Sifri, R.4
LoPresti, L.5
Haddow, J.E.6
-
4
-
-
34848873795
-
Validity of models for predicting BRCA1 and BRCA2 mutations
-
Parmigiani G, Chen S, Iversen ES Jr, et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 2007;147(7):441-450. (Pubitemid 351664516)
-
(2007)
Annals of Internal Medicine
, vol.147
, Issue.7
, pp. 441-450
-
-
Parmigiani, G.1
Chen, S.2
Iversen Jr., E.S.3
Friebel, T.M.4
Finkelstein, D.M.5
Anton-Culver, H.6
Ziogas, A.7
Weber, B.L.8
Eisen, A.9
Malone, K.E.10
Daling, J.R.11
Hsu, L.12
Ostrander, E.A.13
Peterson, L.E.14
Schildkraut, J.M.15
Isaacs, C.16
Corio, C.17
Leondaridis, L.18
Tomlinson, G.19
Amos, C.I.20
Strong, L.C.21
Berry, D.A.22
Weitzel, J.N.23
Sand, S.24
Dutson, D.25
Kerber, R.26
Peshkin, B.N.27
Euhus, D.M.28
more..
-
6
-
-
3543088730
-
Genetic cancer risk assessment and counseling: Recommendations of the national society of genetic counselors
-
DOI 10.1023/B:JOGC.0000018821.48330.77
-
Trepanier A, Ahrens M, McKinnon W, et al. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns. 2004;13(2):83-114. (Pubitemid 39024176)
-
(2004)
Journal of Genetic Counseling
, vol.13
, Issue.2
, pp. 83-114
-
-
Trepanier, A.1
Ahrens, M.2
McKinnon, W.3
Peters, J.4
Stopfer, J.5
Grumet, S.C.6
Manley, S.7
Culver, J.O.8
Acton, R.9
Larsen-Haidle, J.10
Correia, L.A.11
Bennett, R.12
Pettersen, B.13
Ferlita, T.D.14
Costalas, J.W.15
Hunt, K.16
Donlon, S.17
Skrzynia, C.18
Farrell, C.19
Callif-Daley, F.20
Vockley, C.W.21
more..
-
7
-
-
70349665340
-
Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: A call for dialogue
-
Rubinstein WS, Jiang H, Dellefave L, Rademaker AW. Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue. Genet Med. 2009;11(9):629-639.
-
(2009)
Genet Med
, vol.11
, Issue.9
, pp. 629-639
-
-
Rubinstein, W.S.1
Jiang, H.2
Dellefave, L.3
Rademaker, A.W.4
|